Skip to main content
Clinical Trials/NCT02806037
NCT02806037
Completed
Not Applicable

Utility of Intra-operative Image Guidance System for Missing Metastases

Memorial Sloan Kettering Cancer Center0 sites25 target enrollmentNovember 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colorectal Cancer
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
25
Primary Endpoint
localization rate of liver tumor
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Intraoperatively, the surgeon will interrogate the liver with ultrasound. The time spent by the surgeon using the ultrasound is recorded. If all lesions seen on pre-op imaging were found, the patient does not have the Pathfinder Explorer system applied. If one or more lesions cannot be found, then the Pathfinder Explorer system is calibrated and a tracking device is attached to the ultrasound probe, which the surgeon will use to reattempt localization of the missing tumor. The Pathfinder Explorer system operates in real-time in conjunction with the ultrasound.

Registry
clinicaltrials.gov
Start Date
November 2015
End Date
February 26, 2021
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • patient has one or more colorectal liver metastases, at least one of which is ≤1.5cm in maximal diameter on pre-operative cross sectional imaging
  • undergoing liver resection and/or ablation

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

localization rate of liver tumor

Time Frame: 1 year

estimate the localization rate of Pathfinder to within +/-7%.

Similar Trials